Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors.

MLA

Schneeweiss S, et al. “Outcomes of Reference Pricing for Angiotensin-Converting-Enzyme Inhibitors.” New England Journal of Medicine, vol. 346, no. 11, Mar. 2002, pp. 822–29. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=106808603&authtype=sso&custid=ns315887.

APA

Schneeweiss S, Walker AM, Glynn RJ, Maclure M, Dormuth C, & Soumerai SB. (2002). Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors. New England Journal of Medicine, 346(11), 822–829.

Chicago

Schneeweiss S, Walker AM, Glynn RJ, Maclure M, Dormuth C, and Soumerai SB. 2002. “Outcomes of Reference Pricing for Angiotensin-Converting-Enzyme Inhibitors.” New England Journal of Medicine 346 (11): 822–29. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=106808603&authtype=sso&custid=ns315887.